Trials / Completed
CompletedNCT02833584
Safety of Paracetamol as Antipyretic in Treatment of Dengue Infection in Adults
- Status
- Completed
- Phase
- N/A
- Study type
- Interventional
- Enrollment
- 123 (actual)
- Sponsor
- Phramongkutklao College of Medicine and Hospital · Academic / Other
- Sex
- All
- Age
- 18 Years – 99 Years
- Healthy volunteers
- Not accepted
Summary
The purpose of this study is to determine whether regular dosage of paracetamol causes transaminitis (hepatitis) and evaluate its potency in the treatment of dengue infection.
Conditions
Interventions
| Type | Name | Description |
|---|---|---|
| DRUG | Paracetamol | Paracetamol 500 mg x 1 tablets according to patient's body weight |
| DRUG | Placebo | Placebo 500 mg x 1 tablets according to patient's body weight |
Timeline
- Start date
- 2016-09-01
- Primary completion
- 2017-12-01
- Completion
- 2018-01-01
- First posted
- 2016-07-14
- Last updated
- 2019-04-23
Locations
3 sites across 1 country: Thailand
Source: ClinicalTrials.gov record NCT02833584. Inclusion in this directory is not an endorsement.